Barclays Maintains Equal Weight Rating on Surgery Partners (SGRY), Cuts PT
The rating update came after Surgery Partners, Inc. (NASDAQ:SGRY) reported mixed fiscal Q1 2025 results on May 12.
Posts Tagged ‘NASDAQ:SGRY’
Surgery Partners, Inc. (NASDAQ:SGRY) Q1 2025 Earnings Call Transcript
Surgery Partners, Inc. (NASDAQ:SGRY) Q1 2025 Earnings Call Transcript May 12, 2025Surgery Partners, Inc. misses on earnings expectations.
Surgery Partners, Inc. (NASDAQ:SGRY) Q4 2024 Earnings Call Transcript
Operator: Greetings. Welcome to Surgery Partners, Inc. Fourth Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Surgery Partners, Inc. (NASDAQ:SGRY) Q3 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Surgery Partners Third Quarter 2024 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
Surgery Partners, Inc. (NASDAQ:SGRY) Q2 2024 Earnings Call Transcript
Surgery Partners, Inc. (NASDAQ:SGRY) Q2 2024 Earnings Call Transcript August 6, 2024Surgery Partners, Inc. beats earnings expectations.
Here’s Why Surgery Partners (SGRY) Sold Off in Q1
ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” first quarter 2024 investor letter.
Surgery Partners, Inc. (NASDAQ:SGRY) Q1 2024 Earnings Call Transcript
Surgery Partners, Inc. beats earnings expectations. Reported EPS is $0.2628, expectations were $0.07.
Should You Invest in Surgery Partners (SGRY)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Surgery Partners, Inc. (NASDAQ:SGRY) Q4 2023 Earnings Call Transcript
Surgery Partners, Inc. beats earnings expectations. Reported EPS is $0.44, expectations were $0.37. Surgery Partners, Inc.
Jim Cramer Says Do Not Buy These 11 Stocks
In this article, we will take a detailed look at the Jim Cramer Says Do Not Buy These 11 Stocks. For a quick overview of such stocks, read our article Jim Cramer Says Do Not...
Jim Cramer Says You Should Stay Away from These 10 Stocks
In this article, we will take a detailed look at the Jim Cramer Says You Should Stay Away from These 10 Stocks. For a quick overview of such stocks, read our article Jim Cramer...
Is Surgery Partners (SGRY) a Good Long-Term Stock?
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Here’s Why Surgery Partners (SGRY) Declined in Q3
ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” third quarter 2023 investor letter.
Surgery Partners, Inc. (NASDAQ:SGRY) Q3 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to Surgery Partners' Third Quarter of 2023 Earnings Call. Currently, all participants are in listen-only mode.
Surgery Partners, Inc. (NASDAQ:SGRY) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Surgery Partners Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Surgery Partners, Inc. (NASDAQ:SGRY) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Surgery Partners First Quarter 2023 Earnings Call. At this time all participants are in a listen-only mode.
12 Most Promising Healthcare Stocks According to Analysts
In this article, we will take a look at the 12 most promising healthcare stocks according to analysts.
Surgery Partners, Inc. (NASDAQ:SGRY) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to the Surgery Partners, Inc. Fourth Quarter 2022 Earnings Call. At this time all participants are in a listen-only mode.
Surgery Partners, Inc. (NASDAQ:SGRY) Q3 2022 Earnings Call Transcript
Operator: Greetings, and welcome to the Surgery Partners, Inc. Third Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode.
Surgery Partners (SGRY) Stock Dropped in the Third Quarter
ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” third quarter 2022 investor letter.
10 Best Mid-Cap Stocks To Buy According To Billionaire Brian Higgins
In this article, we presented the 10 best mid-cap stocks to buy according to billionaire Brian Higgins.
Is SGRY A Good Stock To Buy Now?
In this article we will analyze whether Surgery Partners, Inc.
Hedge Funds Are Selling Surgery Partners, Inc. (SGRY)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Have Never Been More Bullish On Surgery Partners, Inc. (SGRY)
The market has been volatile in the last few months as the Federal Reserve finalized its rate cuts and uncertainty looms over trade negotiations with China.
Here’s What Hedge Funds Think About Surgery Partners, Inc. (SGRY)
Is Surgery Partners, Inc. (NASDAQ:SGRY) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research.
Surgery Partners Inc (SGRY): Are Hedge Funds Right About This Stock?
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable...
